Detailed site distribution of melanoma and sunlight exposure: Aetiological patterns from a Swiss series

Annals of Oncology

Volumn 18, Issue 4, 2007, Pages 789-794

  Bulliard, Jean Luc ^a   De Weck, D ^b   Fisch, T ^c,g   Bordoni, A ^d   Levi, F ^a,e,f  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b Registre Valaisan des Tumeurs   (Switzerland)

^c Cancer Registry St Gallen Appenzell   (Switzerland)

^d Registro dei Tumori del Canton Ticino   (Switzerland)

^e Registre Vaudois des Tumeurs   (Switzerland)

^f Registre Neuchatelois des Tumeurs   (Switzerland)

^g Krebsregister der Kantone Zürich   (Switzerland)

Author keywords

Aetiology; Anatomical site; Melanoma; Sun exposure; Switzerland

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARM; ARTICLE; BACK; CHILD; CONTROLLED STUDY; FACE; FEMALE; HUMAN; INFANT; LEG; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; RISK ASSESSMENT; SHOULDER; SUN EXPOSURE; SWITZERLAND;

EID: 34047173130     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl490     Document Type: Article

References (37)

1. Garbe C, Büttner P, Bertz J et al. Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer 1995; 75: 2492-2498.
2. Lee JAH, Merrill JM. Sunlight and the aetiology of malignant melanoma: A synthesis. Med J Aust 1970; 2: 846-851.
3. Green A. A theory of site distribution of melanoma: Queensland, Australia. Cancer Causes Control 1992; 3: 513-516.
4. Franceschi S, Levi F, Randimbison L, La Vecchia C. Site distribution of different types of skin cancer: New aetiological clues. Int J Cancer 1996; 66: 1-5.
5. Bulliard J-L. Site-specific risk of cutaneous malignant melanoma and pattern of sun exposure in New Zealand. Int J Cancer 2000; 85: 627-632.
6. Armstrong BK, Kricker A. Epidemiology of sun exposure and skin cancer. Cancer Surv 1996; 26: 133-153.
7. Szabo G. The regional anatomy of the human integument with special reference to the distribution of hair follicles, sweat glands and melanocytes. Philos Trans R Soc Lond 1967; 252: 447-485.
8. Whiteman DC, Parsons PG, Green AC. p53 expression and risk factors for cutaneous melanoma: A case-control study. Int J Cancer 1998; 77: 843-848.
9. Whiteman DC, Watt P, Purdie DM et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 2003; 95: 806-812.
10. Rivers JK. Is there more than one road to melanoma? Lancet 2004; 363: 728-730.
11. Maldonado JL, Fridlyand J, Patel H et al. Determinants of BRAF mutations in primary melanoma. J Natl Cancer Inst 2003; 95: 1878-1890.
12. Elwood JM, Gallagher RP. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int J Cancer 1998; 78: 276-280.
13. Green A, MacLennan R, Youl P, Martin NG. Site distribution of cutaneous melanoma in Queensland. Int J Cancer 1993; 53: 232-236.
14. Osterlind A, Hou-Jensen K, Moller Jensen O. Incidence of cutaneous malignant melanoma in Denmark 1978-1982. Anatomic site distribution, histologic types, and comparison with non-melanoma skin cancer. Br J Cancer 1988; 58: 385-391.
15. Parkin DM, Whelan SL, Ferlay J et al. Cancer Incidence in Five Continents. Lyon, France: International Agency for Research on Cancer, IARC Scientific Publication No 155 2002.
16. Levi F, Erler G, Te VC et al. Trends in skin cancer incidence in Neuchâtel, 1976-98. Tumori 2001; 87: 288-289.
17. Levi F, La Vecchia C, Te VC, Mezzanotte G. Descriptive epidemiology of skin cancer in the Swiss Canton of Vaud. Int J Cancer 1988; 42: 811-816.
18. Bulliard J-L, De Weck D, Fisch T, Levi F. Population-based collection of phenotypic and familial information on melanoma patients: A feasibility study. Schweiz Krebs Bull 2005; 25: 131-135.
19. Bulliard J-L, Levi F. Site misclassification of melanoma in the shoulder region: An issue not to be 'shrugged at'? Arch Dermatol 2005; 141: 1047-1049.
20. World Health Organization. International Classification of Diseases for Oncology, third edition. Geneva: WHO 2000.
21. World Health Organization. Tumor-Lokalisationsschl̈ussel. International Classification of Diseases for Oncology, Topographischer Teil. In Wagner G (ed), 5th Edition. Berlin: Springer-Verlag 1993; 48-51.
22. Lund CC, Browder NC. The estimation of areas of burns. Surg Gynecol Obstet 1944; 79: 352-358.
23. Elwood JM, Gallagher RP. Site distribution of malignant melanoma. Can Med Assoc J 1983; 128: 1400-1404.
24. Pearl DK, Scott EL. The anatomical distribution of skin cancers. Int J Epidemiol 1986; 15: 502-506.
25. World Health Organization. International Classification of Diseases for Oncology. Geneva: WHO 1976.
26. Green A, McCredie M, Giles G, Jackman L. Re: 'Occurrence of melanoma on the upper and lower limbs in eastern Australia' [letter]. Melanoma Res 1997; 7: 437.
27. Naldi L, Altieri A, Imberti GL et al. Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinicopathological variants and anatomic locations (Italy). Cancer Causes Control 2005; 16: 893-899.
28. Elder DE. Skin cancer. Melanoma and other specific nonmelanoma skin cancers. Cancer 1995; 75: 245-256.
29. Bulliard J-L, Cox B, Elwood JM. Comparison of the site distribution of melanoma in New Zealand and Canada. Int J Cancer 1997; 72: 231-235.
30. Moehrle M, Garbe C. Does mountaineering increase the incidence of cutaneous melanoma? A hypothesis based on cancer registry data. Dermatology 1999; 199: 201-203.
31. Green A, McCredie M, Giles G, Jackman L. Occurrence of melanoma on the upper and lower limbs in eastern Australia. Melanoma Res 1996; 6: 387-394.
32. van der Spek-Keijser LMT, van der Rhee HJ, Toth G et al. Site, histological type, and thickness of primary cutaneous malignant melanoma in western Netherlands since 1980. Br J Dermatol 1997; 136: 565-571.
33. Bulliard J-L, Cox B. Cutaneous malignant melanoma in New Zealand: Trends by anatomical site, 1969-1993. Int J Epidemiol 2000; 29: 416-423.
34. Bulliard J-L, Cox B, Semenciw R. Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969-93. Cancer Causes Control 1999; 10: 407-416.
35. Chen YT, Zheng T, Holford TR et al. Malignant melanoma incidence in Connecticut (United States): Time trends and age-period-cohort modeling by anatomic site. Cancer Causes Control 1994; 5: 341-350.
36. MacKie RM, Bray CA, Hole DJ et al. Incidence of and survival from malignant melanoma in Scotland: An epidemiological study. Lancet 2002; 360: 587-591.
37. Tikuisis P, Meunier P, Jubenville CE. Human body surface area: measurement and prediction using three dimensional body scans. Eur J Appl Physiol 2001; 85: 264-271.